Intel’s Seventh Guidance Beat Keeps the Recovery Narrative Alive, but DeepValue Stays on WAIT

What happened

Intel posted its seventh consecutive quarter above guidance, with Q2 2026 revenue of $16.1 billion crushing the midpoint by $1.8 billion and non‑GAAP EPS of $0.42, drawing an upgrade to buy from a Seeking Alpha analyst. The article flags a fresh geopolitical risk: Intel’s Israeli fabrication facility lacks war insurance and was named on Iran’s retaliation target list. The DeepValue master report already incorporated the Q2 beat and judges the stock richly valued at 37.7× EV/EBITDA after a 330% rally, with external foundry validation still missing and DCAI growth still ASP‑led. The next decisive catalyst remains Intel 14A’s PDK 0.9 release in October 2026 and a possible external design win. For now, the setup calls for patience rather than fresh buying, as the market is crowded and the upside needs hard proof of unit‑driven server growth and foundry customer commitments.

Implication

Intel’s consistent guidance beats show the turnaround is real, yet the stock has already priced in much of that recovery. The key missing ingredient is an external 14A or advanced packaging customer commitment that would de‑risk capex and justify a higher multiple. Without that proof, the current entry is unattractive; investors should use strength to trim and wait for a re‑entry near $85 or a named third‑party win that changes the narrative from internal turnaround to commercial foundry validation. The Israeli geopolitical risk adds a new tail event to monitor but does not alter the base case.

Thesis delta

The seventh consecutive beat reinforces the operational recovery but does not change the central thesis: the stock already reflects a crowded turnaround narrative, and the rerating to a higher valuation tier still depends on external foundry wins and a shift to unit‑led server growth. The upgrade to buy by one author ignores the stretched valuation and the concentrated, ASP‑driven nature of the rebound—no adjustment to the WAIT rating or $85 attractive entry is warranted.